Apr 12 (Reuters)-
Pharmarise Holdings Corp
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Feb 29, 2016 Feb 28, 2015 May 31, 2016
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 35.07 29.23 48.50
(+20.0 pct) (+5.1 pct) (+22.8 pct)
Operating 726 mln 768 mln 975 mln
(-5.4 pct) (-30.4 pct) (-14.7 pct)
Recurring 602 mln 607 mln 755 mln
(-0.8 pct) (-31.0 pct) (-24.3 pct)
Net 662 mln 141 mln 515 mln
(+367.2 pct) (-49.5 pct) (+126.0 pct)
EPS 73.51 yen 15.74 yen 57.18 yen
EPS Diluted 72.03 yen 15.56 yen
Ann Div 16.00 yen 14.00 yen
-Q2 div NIL NIL
-Q4 div 16.00 yen 14.00 yen
NOTE - Pharmarise Holdings Corp.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2796.T
((Tokyo Headline News Desk +813 6441 1812))